{"slideshow_credits": null, "snippet": "The decision to allow adolescents to buy the pill without a prescription has done nothing to improve the stock value of Teva Pharmaceuticals, the company that makes Plan B One-Step.", "abstract": "Obama administration decision to allow adolescents to buy emergency birth-control pill without a prescription has done nothing to improve the stock value of Teva Pharmaceuticals, company that makes Plan B One-Step; it had relatively small $93 million in sales from drug over past year.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": "Pam Belluck contributed reporting."}, "web_url": "http://www.nytimes.com/2013/06/12/business/lifting-restrictions-of-morning-after-pill-has-little-impact-for-drug-maker.html", "lead_paragraph": "The decision to allow adolescents to buy the pill without a prescription has done nothing to improve the stock value of Teva Pharmaceuticals, the company that makes Plan B One-Step.", "headline": {"main": "Lifting Restrictions of \u2018Morning After\u2019 Pill Has Little Impact for Drug Maker", "print_headline": "Lifting Restrictions of \u2018Morning After\u2019 Pill Has Little Impact for Drug Maker"}, "_id": "51b8868f7e0d9c0839d27297", "word_count": "787", "multimedia": [{"height": 126, "url": "images/2013/06/12/business/SUB-DRUG/SUB-DRUG-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/12/business/SUB-DRUG/SUB-DRUG-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 484, "url": "images/2013/06/12/business/SUB-DRUG/SUB-DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2013/06/12/business/SUB-DRUG/SUB-DRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "484"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/06/12/business/SUB-DRUG/SUB-DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/12/business/SUB-DRUG/SUB-DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-12T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Plan B (Contraceptive)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Women and Girls", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Drugstores", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Birth Control and Family Planning", "name": "subject", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}